Diffuse Large B Cell Lymphoma Clinical Trials in Fuzhou, Fujian
6 recruitingFuzhou, Fujian, China
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Diffuse Large B Cell Lymphoma
Merck Sharp & Dohme LLC1,046 enrolled246 locationsNCT06717347
Recruiting
Phase 3
A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Diffuse Large B Cell Lymphoma
Genmab360 enrolled177 locationsNCT06508658
Recruiting
Phase 1Phase 2
Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma
Diffuse Large B Cell Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.90 enrolled25 locationsNCT06829771
Recruiting
Drug-Eluting Bead-Based Transarterial Chemoembolization (DEB-TACE) as a Local Salvage Therapy for Large Lesions in Relapsed and Refractory Diffuse Large B-Cell Lymphoma
Diffuse Large B Cell LymphomaTransarterial ChemoembolizationRelapsed and Refractory
Ting YANG10 enrolled1 locationNCT07198230
Recruiting
Metabolic and Immunomic Differential Analysis of Primary Central Nervous System Diffuse Large B-Cell Lymphoma
Diffuse Large B Cell LymphomaPrimary Central Nervous System Lymphoma (PCNSL)
Ting YANG20 enrolled1 locationNCT07188077
Recruiting
Phase 1Phase 2
Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL
Diffuse Large B Cell Lymphoma
Sun Yat-sen University112 enrolled10 locationsNCT06760039